One-year Prospective, Observational Study of the Journey of Patients With Plaque Psoriasis Prescribed Calcipotriol/Betamethasone Aerosol Foam or Other Topical Therapy

Trial Profile

One-year Prospective, Observational Study of the Journey of Patients With Plaque Psoriasis Prescribed Calcipotriol/Betamethasone Aerosol Foam or Other Topical Therapy

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary)
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Acronyms PSOREAL
  • Sponsors LEO Pharma
  • Most Recent Events

    • 28 Jun 2017 Planned number of patients changed from 15000 to 5000.
    • 17 Jan 2017 Status changed from not yet recruiting to recruiting.
    • 21 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top